MonoSol appoints Director of Marketing and Business Development

Christian Hermanns will help foster the future growth of the US company

MonoSol, a US developer of water-soluble delivery systems, has added a new member of staff to its team. Christian Herrmanns has joined the firm as Director of Marketing and Business Development.

Herrmanns has previously worked in new business development, product innovation and strategic marketing in several multinational companies. He has studied and worked in Germany, Switzerland, the US and China.

'We are extremely happy to have Christian leading MonoSol’s Technical Marketing Team and fostering our growth into the future,' said Scott Bening, CEO of MonoSol.

You may also like

Manufacturing

CPI collaborates with industry leaders to expedite drug manufacturing via digitisation

Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Marketing

Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation

The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Manufacturing

Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide

CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
Regulatory

Tivdak receives US FDA approval for treating recurrent cervical cancer

The full approval of tisotumab vedotin will offer a treatment for patients with metastatic or recurrent cervical cancer exhibiting disease progression on or after chemotherapy
Manufacturing

Marchesini Group at Achema 2024: celebrating 50 years of innovation

At G3, Hall 3.1, the Marchesini Group will exhibit pharmaceutical manufacturing machines, packaging solutions and digital tools to enhance manufacturing processes
Manufacturing

US court lifts modified consent decree on Xellia’s Cleveland facility

The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Manufacturing

Miltenyi Biotec and MiLaboratories collaborate to advance next-generation therapies

Miltenyi Biotec will commercialise MiLaboratories' RNA kit technology for immune sequencing, facilitating advances in the field of personalised medicine
Subscribe now